PepGen Inc.
245 Main Street
Cambridge, Massachusetts 02142
May 3, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Tara Harkins |
Kevin Vaughn
Jane Park
Jeffrey Gabor
| Re: | PepGen Inc. |
Registration Statement on Form S-1, as amended (File No. 333-264335)
Request for Acceleration of Effective Date
To whom it may concern:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, PepGen Inc. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-264335), as amended, be accelerated by the Securities and Exchange Commission to 4:00 p.m. Eastern time, on May 5, 2022, or as soon thereafter as possible.
We request that we be notified of such effectiveness by a telephone call to James Xu of Goodwin Procter LLP at (650) 752 3355 and that such effectiveness also be confirmed in writing.
| Very truly yours, | ||
| PepGen Inc. | ||
| By: | /s/ James McArthur, Ph.D. | |
| Name: James McArthur, Ph.D. | ||
| Title: Chief Executive Officer | ||
| cc: | James Xu, Goodwin Procter LLP |